Lipobay case raises doubts on regulation
Claims by the German and French governments that Bayer failed to warn them of its plans to withdraw the cholesterol-lowering drug Lipobay were thrown into doubt when it emerged that the UK
Claims by the German and French governments that Bayer failed to warn them of its plans to withdraw the cholesterol-lowering drug Lipobay were thrown into doubt when it emerged that the UK